5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Macrophage‐specific hypoxia‐inducible factor‐1α deletion suppresses the development of liver tumors in high‐fat diet‐fed obese and diabetic mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims/Introduction

          Chronic inflammation of the liver is often observed with obesity or type 2 diabetes. In these pathological conditions, the immunological cells, such as macrophages, play important roles in the development or growth of liver cancer. Recently, it was reported that hypoxia‐inducible factor‐1α (HIF‐1α) is a key molecule for the acquisition of inflammatory M1 polarity of macrophages. In the present study, we examined the effects of altered macrophage polarity on obesity‐ and diabetes‐associated liver cancer using macrophage‐specific HIF‐1α knockout (KO) mice.

          Materials and Methods

          To induce liver cancer in the mice, diethylnitrosamine, a chemical carcinogen, was used. Both KO mice and wild‐type littermates were fed either a high‐fat diet ( HFD) or normal chow. They were mainly analyzed 6 months after HFD feeding.

          Results

          Development of liver cancer after HFD feeding was 45% less in KO mice than in wild‐type littermates mice. Phosphorylation of extracellular signal‐regulated kinase 2 was also lower in the liver of KO mice. Those effects of HIF‐1α deletion in macrophages were not observed in normal chow‐fed mice. Furthermore, the size of liver tumors did not differ between KO and wild‐type littermates mice, even those on a HFD. These results suggest that the activation of macrophage HIF‐1α by HFD is involved not in the growth, but in the development of liver cancer with the enhanced oncogenic extracellular signal‐regulated kinase 2 signaling in hepatocytes.

          Conclusions

          The activation of macrophage HIF‐1α might play important roles in the development of liver cancer associated with diet‐induced obesity and diabetes.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Macrophage regulation of tumor responses to anticancer therapies.

          Tumor-associated macrophages (TAMs) promote key processes in tumor progression, like angiogenesis, immunosuppression, invasion, and metastasis. Increasing studies have also shown that TAMs can either enhance or antagonize the antitumor efficacy of cytotoxic chemotherapy, cancer-cell targeting antibodies, and immunotherapeutic agents--depending on the type of treatment and tumor model. TAMs also drive reparative mechanisms in tumors after radiotherapy or treatment with vascular-targeting agents. Here, we discuss the biological significance and clinical implications of these findings, with an emphasis on novel approaches that effectively target TAMs to increase the efficacy of such therapies. Copyright © 2013 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

            It is a challenge to identify patients who, after undergoing potentially curative treatment for hepatocellular carcinoma, are at greatest risk for recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissue. We aimed to demonstrate the feasibility of gene-expression profiling of more than 6000 human genes in formalin-fixed, paraffin-embedded tissues. We applied the method to tissues from 307 patients with hepatocellular carcinoma, from four series of patients, to discover and validate a gene-expression signature associated with survival. The expression-profiling method for formalin-fixed, paraffin-embedded tissue was highly effective: samples from 90% of the patients yielded data of high quality, including samples that had been archived for more than 24 years. Gene-expression profiles of tumor tissue failed to yield a significant association with survival. In contrast, profiles of the surrounding nontumoral liver tissue were highly correlated with survival in a training set of tissue samples from 82 Japanese patients, and the signature was validated in tissues from an independent group of 225 patients from the United States and Europe (P=0.04). We have demonstrated the feasibility of genomewide expression profiling of formalin-fixed, paraffin-embedded tissues and have shown that a reproducible gene-expression signature correlated with survival is present in liver tissue adjacent to the tumor in patients with hepatocellular carcinoma. Copyright 2008 Massachusetts Medical Society.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma.

              The roles of alternatively activated (M2) macrophages on pro-tumour phenotypes have been well documented in many cancers except hepatocellular carcinoma (HCC). Considering their close relationship with chronic tissue injuries as well as enhanced tumour invasiveness and growth, we aimed to investigate the direct effects of M2 macrophages on HCC.
                Bookmark

                Author and article information

                Contributors
                isaousui-tym@umin.ac.jp
                Journal
                J Diabetes Investig
                J Diabetes Investig
                10.1111/(ISSN)2040-1124
                JDI
                Journal of Diabetes Investigation
                John Wiley and Sons Inc. (Hoboken )
                2040-1116
                2040-1124
                11 April 2019
                November 2019
                : 10
                : 6 ( doiID: 10.1111/jdi.v10.6 )
                : 1411-1418
                Affiliations
                [ 1 ] First Department of Internal Medicine University of Toyama Toyama Japan
                [ 2 ] Department of Endocrinology and Metabolism Dokkyo Medical University Tochigi Japan
                [ 3 ] Department of Pathology and Laboratory Medicine Institute of Biomedical Sciences Tokushima University Graduate School Tokushima Japan
                [ 4 ] Department of Metabolism and Nutrition Graduate School of Medicine and Pharmaceutical Science for Research University of Toyama Toyama Japan
                [ 5 ] Division of Pathogenic Biochemistry Department of Bioscience Institute of Natural Medicine University of Toyama Toyama Japan
                Author notes
                [*] [* ] Correspondence

                Isao Usui

                Tel.: +81‐282‐87‐2150

                Fax: +81‐282‐86‐4632

                E‐mail address: isaousui-tym@ 123456umin.ac.jp

                Author information
                https://orcid.org/0000-0002-4720-4882
                https://orcid.org/0000-0001-5539-7605
                https://orcid.org/0000-0003-0015-0255
                Article
                JDI13047
                10.1111/jdi.13047
                6825928
                30897274
                90caa68c-5d1f-4a5f-a0ff-ae1838a9e091
                © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 06 September 2018
                : 12 March 2019
                : 15 March 2019
                Page count
                Figures: 4, Tables: 0, Pages: 8, Words: 4607
                Funding
                Funded by: Japan Society for the Promotion of Science
                Award ID: 17K16143
                Award ID: 25461333
                Award ID: 26461327
                Funded by: Japan Foundation for Applied Enzymology
                Categories
                Original Article
                Articles
                Basic Science and Research
                Custom metadata
                2.0
                jdi13047
                November 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.7.0 mode:remove_FC converted:03.11.2019

                hypoxia‐inducible factor‐1α,liver cancer,macrophage

                Comments

                Comment on this article